Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
DUOPHARMA BIOTECH BERHAD |
Particulars of substantial Securities Holder
Name | EMPLOYEES PROVIDENT FUND BOARD |
Address |
TINGKAT 19, BANGUNAN KWSP, JALAN RAJA LAUT
KUALA LUMPUR 50350 Wilayah Persekutuan Malaysia. |
Company No. | EPF ACT 1991 |
Nationality/Country of incorporation | Malaysia |
Descriptions (Class) | Ordinary Shares |
Details of changes
No | Date of change | No of securities |
Type of Transaction | Nature of Interest |
06 Aug 2020 | 260,500 |
Disposed | Direct Interest | |
Name of registered holder | Citigroup Nominees (Tempatan) Sdn. Bhd. | |||
Address of registered holder | Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur. | |||
Description of "Others" Type of Transaction |
Circumstances by reason of which change has occurred | Disposal of 260,500 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board |
Nature of interest | Indirect Interest |
Direct (units) | |
Direct (%) | |
Indirect/deemed interest (units) | 52,635,589 |
Indirect/deemed interest (%) | 7.691 |
Total no of securities after change | 52,635,589 |
Date of notice | 07 Aug 2020 |
Date notice received by Listed Issuer | 11 Aug 2020 |
Remarks : |
Total number of Duopharma Biotech Berhad shares held are as follows:- (a) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD : 43,997,958 (b) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (AM INV) : 0 (c) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (CIMB PRI) : 6,660,731 (d) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (ARIM) : 400,000 (e) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (TEMPLETON) : 0 (f) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (F.TEMISLAMIC) IC : 0 (g) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (NIAM EQ) IC. : 1,576,900 |
Announcement Info
Company Name | DUOPHARMA BIOTECH BERHAD |
Stock Name | DPHARMA |
Date Announced | 11 Aug 2020 |
Category | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 |
Reference Number | CS2-11082020-00028 |